Fig 2.

Kinetics of HCV viral loads between baseline and week 12. (A) Kinetics of HCV viral loads between baseline and week 12 during a previous course of dual therapy. Patients 1 and 4 were relapsers. Patient 5 data are unavailable. (B) Differences in HCV viral load (log₁₀ IU/ml) for patients 1 and 4 between dual therapy and triple therapy from week 0 to week 12. (C) Kinetics of HCV viral loads between baseline and week 12 during triple therapy. At baseline, the mean HCV viral load (HVL) was 6.87 ± 0.70 log₁₀ IU/ml (range, 6.30 to 7.97). Boceprevir was started in week 4, at 800 mg three times a day. The mean decrease in the HVL between baseline and week 12 was 6.64 ± 0.35 log₁₀ IU/ml (range, 6.30 to 7.10).